PUBLIC COMPANY
saveSpringWorks Therapeutics Inc
updated 1mo ago
community read0 votes
pipeline
5
marketed
2
phase 3
0
catalysts ytd
1
approvals ytd
1
recalls ytd
0
Pipeline(5)
pipeline depth5 products
1Phase 11Phase 22Marketed1Unknown
Marketed
mirdametinib ODT
Neurofibromatoses Type I (Von Recklinghausen's Disease)
Marketednirogacestat hydrobromide
Desmoid Tumors
Phase 2mirdametinib
Non-Small Cell Lung Cancer
Dual specificity mitogen-activated protein kinase kinase 1Dual specificity mitogen-activated protein kinase kinase 2
Phase 1SW-682
Malignant Mesothelioma
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that